Literature DB >> 24817935

Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a.

Vanessa Villegas-Ruiz1, Sergio Juárez-Méndez2, Oscar A Pérez-González2, Hugo Arreola1, Lucero Paniagua-García1, Miriam Parra-Melquiadez1, Raúl Peralta-Rodríguez1, Ricardo López-Romero1, Alberto Monroy-García3, Alejandra Mantilla-Morales4, Guillermo Gómez-Gutiérrez5, Edgar Román-Bassaure6, Mauricio Salcedo1.   

Abstract

In recent years, the study of microRNAs associated with neoplastic processes has increased. Patterns of microRNA expression in different cell lines and different kinds of tumors have been identified; however, little is known about the alterations in regulatory pathways and genes involved in aberrant set of microRNAs. The identification of these altered microRNAs in several cervical cancer cells and potentially deregulated pathways involved constitute the principal goals of the present study. In the present work, the expression profiles of cellular microRNAs in Cervical Cancer tissues and cell lines were explored using microRNA microarray, Affymetrix. The most over-expressed was miR-196a, which was evaluated by real time PCR, and HOXC8 protein as potential target by immunohistochemistry assay. One hundred and twenty three human microRNAs differentially expressed in the cell tumor, 64 (52%) over-expressed and 59 (48%) under-expressed were observed. Among the microRNAs over-expressed, we focused on miR-196a; at present this microRNA is poorly studied in CC. The expression of this microRNA was evaluated by qRT-PCR, and HOXC8 by immunohistochemistry assay. There is not a specific microRNA expression profile in the CC cells, neither a microRNA related to HPV presence. Furthermore, the miR-196a was over-expressed, while an absence of HOXC8 expression was observed. We suggest that miR-196a could be played as oncomiR in CC.

Entities:  

Keywords:  Cervical cancer; HOXC8; miR-196a; microRNAs

Mesh:

Substances:

Year:  2014        PMID: 24817935      PMCID: PMC4014219     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  48 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR.

Authors:  J Robin Lytle; Therese A Yario; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

3.  HOXB homeobox gene expression in cervical carcinoma.

Authors:  R López; E Garrido; P Piña; A Hidalgo; M Lazos; R Ochoa; M Salcedo
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

4.  Altered MicroRNA expression in cervical carcinomas.

Authors:  Jeong-Won Lee; Chel Hun Choi; Jung-Joo Choi; Young-Ae Park; Seung-Jun Kim; Seung Yong Hwang; Woo Young Kim; Tae-Joong Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

5.  MicroRNAs in cancer treatment and prognosis.

Authors:  Cláudia Regina Gasque Schoof; Eder Leite da Silva Botelho; Alberto Izzotti; Luciana Dos Reis Vasques
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

6.  Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.

Authors:  Markus Schmitt; Bolormaa Dondog; Tim Waterboer; Michael Pawlita
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

7.  Proteomic patterns of cervical cancer cell lines, a network perspective.

Authors:  Juan Carlos Higareda-Almaraz; María del Rocío Enríquez-Gasca; Magdalena Hernández-Ortiz; Osbaldo Resendis-Antonio; Sergio Encarnación-Guevara
Journal:  BMC Syst Biol       Date:  2011-06-22

8.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.

Authors:  Young-Kook Kim; Jieun Yu; Tae Su Han; Seong-Yeon Park; Bumjin Namkoong; Dong Hyuk Kim; Keun Hur; Moon-Won Yoo; Hyuk-Joon Lee; Han-Kwang Yang; V Narry Kim
Journal:  Nucleic Acids Res       Date:  2009-01-19       Impact factor: 16.971

9.  MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.

Authors:  B Diosdado; M A van de Wiel; J S Terhaar Sive Droste; S Mongera; C Postma; W J H J Meijerink; B Carvalho; G A Meijer
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

10.  Prognostic Values of microRNAs in Colorectal Cancer.

Authors:  Yaguang Xi; Andrea Formentini; Minchen Chien; David B Weir; James J Russo; Jingyue Ju; Marko Kornmann; Jingfang Ju
Journal:  Biomark Insights       Date:  2006
View more
  22 in total

1.  MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer.

Authors:  Zhenfeng Hao; Jishi Yang; Chenghai Wang; Yaoyao Li; Yu Zhang; Xiaoyun Dong; Liulin Zhou; Jing Liu; Yanqing Zhang; Jing Qian
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Emerging links between endosomal pH and cancer.

Authors:  Myungjun Ko; Alfredo Quiñones-Hinojosa; Rajini Rao
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

Review 3.  HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers.

Authors:  Marina Di Domenico; Giancarlo Giovane; Soumaya Kouidhi; Rosamaria Iorio; Maurizio Romano; Francesco De Francesco; Antonia Feola; Camilla Siciliano; Luigi Califano; Antonio Giordano
Journal:  Cancer Biol Ther       Date:  2018-05-14       Impact factor: 4.742

4.  Effect and mechanism of microRNA-10b on proliferation and invasion of esophageal cancer cells.

Authors:  Yi Liu; Adili Salai; Dan He; Shengli Gao; Wei Zeng
Journal:  Exp Ther Med       Date:  2019-08-26       Impact factor: 2.447

Review 5.  The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis.

Authors:  Zhen-Yao Chen; Xin Chen; Zhao-Xia Wang
Journal:  Tumour Biol       Date:  2016-10-18

6.  Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.

Authors:  Mysore S Veena; Santanu Raychaudhuri; Saroj K Basak; Natarajan Venkatesan; Parameet Kumar; Roopa Biswas; Rita Chakrabarti; Jing Lu; Trent Su; Marcus Gallagher-Jones; Marco Morselli; Haiqing Fu; Matteo Pellegrini; Theodore Goldstein; Mirit I Aladjem; Matthew B Rettig; Sharon P Wilczynski; Daniel Sanghoon Shin; Eri S Srivatsan
Journal:  J Biol Chem       Date:  2020-10-07       Impact factor: 5.157

7.  miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.

Authors:  Lei Cheng; Beihua Kong; Ying Zhao; Jie Jiang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

8.  Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.

Authors:  Ying Han; Guang-Xu Xu; Huan Lu; Dan-Hua Yu; Yuan Ren; Li Wang; Xu-Hong Huang; Wen-Jing Hou; Zhen-Hong Wei; Yuan-Ping Chen; Yun-Gui Cao; Rong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 9.  Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer.

Authors:  Nima Hemmat; Ahad Mokhtarzadeh; Mohammad Aghazadeh; Farhad Jadidi-Niaragh; Behzad Baradaran; Hossein Bannazadeh Baghi
Journal:  Mol Biol Rep       Date:  2020-05-07       Impact factor: 2.742

10.  Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers.

Authors:  Antonia Kolokythas; Yalu Zhou; Joel L Schwartz; Guy R Adami
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.